CRE Forum 2024: Developments in reducing antimicrobial resistance through optimised dosing

Join CRE RESPOND for their 2024 Forum to hear the latest updates and developments in reducing antimicrobial resistance through optimised dosing.

Over the past two and a half years, our team, together with PhD students, has actively collaborated with centres and hospitals worldwide to continue our activity around optimised antimicrobial use. This forum will present some of our most recent exciting data and we hope that it will provide a springboard from which to plan for future innovations in clinical practice in infectious disease.

CRE RESPOND offers light lunch to those attending in person from 1pm. Zoom link will be provided to those attending the seminar online.

1–1:30pm Arrivals and light lunch

1:30pm AEST Session 1: Translating research into practice
Chair: Professor Jason Roberts, Director, UQCCR and CRE RESPOND, Brisbane, Australia

3:20pm AEST Session 2: Preclinical studies and clinical pharmacokinetics
Chair: Professor Jan De Waele, Ghent University Hospital, Belgium

4:40pm AEST Session 3: Translating dosing into practice change and regulation 
Chair: Associate Professor Sandy Peake, Queen Elizabeth Hospital, Adelaide, Australia

 6:15pm AEST Forum concludes

Thank you to our sponsors: